PharmOncology

Why don't we have a pan-tumor drug that targets BRCA mutations?


Listen Later

The challenges of targeting BRCA mutations in all cancers


Tumor lineage shapes BRCA-mediated phenotypes: https://pmc.ncbi.nlm.nih.gov/articles/PMC7048239/

...more
View all episodesView all episodes
Download on the App Store

PharmOncologyBy Ming-Hei Tai